Fulcrum Therapeutics (FULC) Other Working Capital Changes (2018 - 2026)

Fulcrum Therapeutics (FULC) has reported Other Working Capital Changes for 9 consecutive years, with -$2.2 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Other Working Capital Changes fell 878.47% year-over-year to -$2.2 million; the TTM figure through Jun 2026 stood at -$2.2 million (up 5.62% YoY), while the FY2025 annual figure was -$1.6 million, up 18.44% from the prior year.
• Other Working Capital Changes retreated to -$2.2 million in Q2 2026 per FULC's latest filing, from $179000.0 in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $1.7 million in Q4 2023 and bottomed at -$2.2 million in Q2 2026.
• Historically, Other Working Capital Changes has averaged -$466722.2 across 5 years, with a median of -$424000.0 in 2022.
• Annual changes were most pronounced in 2023 — Other Working Capital Changes soared 467.47% — and 2026, when it sank 878.47%.
• Fulcrum Therapeutics' Other Working Capital Changes stood at -$455000.0 in 2022, then jumped by 467.47% to $1.7 million in 2023, then slumped by 103.95% to -$66000.0 in 2024, then jumped by 33.33% to -$44000.0 in 2025, then slumped by 4995.45% to -$2.2 million in 2026.
• Business Quant data shows FULC's Other Working Capital Changes at -$2.2 million in Q2 2026, $179000.0 in Q1 2026, and -$44000.0 in Q4 2025.